Correction to: Gingerol inhibits cisplatin-induced acute and delayed emesis in rats and minks by regulating the central and peripheral 5-HT, SP, and DA systems

Correction to: Journal of Natural Medicines https://doi.org/10.1007/s11418-019-01372-x

In the original publication of the article, Figures 2, 3, 5, 11 and 13 were published incorrectly. The correct version of Fig. 2, 3, 5, 11 and 13 are given below,

Fig. 2

Representative H&E staining in area postrema along with ileum of rats and minks (100 × magnification). The figures show the H&E staining in area postrema along with ileum of rats and minks (rats: n = 5, minks: n = 6). Bar indicates 100 µm. C normal control group, CG simple gingerol control group, V cisplatin control group, M cisplatin + metoclopramide group, GL cisplatin + low-dose gingerol group, GM cisplatin + middle-dose gingerol group, GH cisplatin + high-dose gingerol group. The red arrow shows the nerve cell, black arrow shows the epithelial cell, and blue arrow shows the inflammatory cell

Fig. 3

5-HT immunostaining expression in area postrema in addition to ileum of rats and minks. a Immunohistochemistry manifestation of 5-HT in area postrema in addition to ileum of rats and minks (rats: n = 5, minks: n = 6). Bar indicates 100 µm. b Mean optical density values of 5-HT. The images were quantified by Image-Pro Plus. C normal control group, CG simple gingerol control group, V cisplatin control group, M cisplatin + metoclopramide group, GL cisplatin + low-dose gingerol group, GM cisplatin + middle-dose gingerol group, GH cisplatin + high-dose gingerol group. ^*P < 0.05 vs. Group C, ^‡P < 0.05 vs. Group CG, ^†P < 0.05 vs. Group V, ^§P < 0.05 vs. Group M, ^||P < 0.05 vs. Group GL, ^¶P < 0.05 vs. Group GM. 5-HT 5-tyrosine hydroxylase

Fig. 5

TPH immunostaining manifestation in area postrema as well as ileum of rats and minks. a Immunohistochemistry manifestation of TPH₂ in area postrema of rats plus minks, and TPH₁ in ileum of rats and minks (rats: n = 5, minks: n = 6). Bar indicates 100 µm. b Mean optical density values of TPH₂ and TPH₁. The images were quantified by Image-Pro Plus. C normal control group, CG simple gingerol control group, V cisplatin control group, M cisplatin + metoclopramide group, GL cisplatin + low-dose gingerol group, GM cisplatin + middle-dose gingerol group, GH cisplatin + high-dose gingerol group. ^*P < 0.05 vs. Group C, ^‡P < 0.05 vs. Group CG, ^†P < 0.05 vs. Group V, ^§P < 0.05 vs. Group M, ^||P < 0.05 vs. Group GL, ^¶P < 0.05 vs. Group GM. TPH₁ tryptophan hydroxylase 1, TPH₂ tryptophan hydroxylase 2

Fig. 11

DA immunostaining expression in area postrema in addition to ileum of rats and minks. a Immunohistochemistry manifestation of DA in area postrema plus ileum of rats and minks (rats: n = 5, minks: n = 6). Bar indicates 100 µm. b Mean optical density values of DA. The images were quantified by Image-Pro Plus. C normal control group, CG simple gingerol control group, V cisplatin control group, M cisplatin + metoclopramide group, GL cisplatin + low-dose gingerol group, GM cisplatin + middle-dose gingerol group, GH cisplatin + high-dose gingerol group. ^*P < 0.05 vs. Group C, ^‡P < 0.05 vs. Group CG, ^†P < 0.05 vs. Group V, ^§P < 0.05 vs. Group M, ^||P < 0.05 vs. Group GL, ^¶P < 0.05 vs. Group GM. DA dopamine

Fig. 13

TH immunostaining manifestation in area postrema in addition to ileum of rats and minks. a Immunohistochemistry manifestation of TH in area postrema plus ileum of rats and minks (rats: n = 5, minks: n = 6). Bar indicates 100 µm. b Mean optical density values of TH. The images were quantified by Image-Pro Plus. C normal control group, CG simple gingerol control group, V cisplatin control group, M cisplatin + metoclopramide group, GL cisplatin + low-dose gingerol group, GM cisplatin + middle-dose gingerol group, GH cisplatin + high-dose gingerol group. ^*P < 0.05 vs. Group C, ^‡P < 0.05 vs. Group CG, ^†P < 0.05 vs. Group V, ^§P < 0.05 vs. Group M, ^||P < 0.05 vs. Group GL, ^¶P < 0.05 vs. Group GM. TH tyrosine hydroxylase